Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

MASH, or metabolic dysfunction-associated steatohepatitis, is a serious liver disease that’s caused by a buildup of fat that becomes inflamed despite a low intake of alcohol. It was formerly ...

In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

Discover a study in which non-selective β-blockers have demonstrated significant potential in preventing decompensation.

Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...

Here, we argue that metabolic dysfunction-associated steatotic liver disease should be considered a non-communicable disease.

More than 40 Brits die every day from fatty liver disease, making it the third leading cause of premature death in the UK. The condition is often associated with drinking too much alcohol (ARLD ...

Long-term exposure to low levels of traffic-related air pollution harms the liver and may raise the risk of metabolic-associated fatty liver disease, a new study in mice suggests.